Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹65.3 Cr 5.4% 15.7% -41.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,698.9 Cr 4.5% 8.3% -18.6% Stock Analytics
KIRI INDUSTRIES ₹2,720.4 Cr -1% 8.6% -35.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,585.0 Cr -1.5% 16.6% -24% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,112.3 Cr 1.5% 13% 38.8% Stock Analytics
BODAL CHEMICALS ₹837.8 Cr -1.4% 52.6% 1% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

5.4%

15.7%

-41.6%

SENSEX

3.2%

5%

5.5%


You may also like the below Video Courses